Bioanalysis Zone announces winner of Rising Star Award 2025
Bioanalysis Zone, the knowledge hub for the bioanalytical industry, has named Abhishek Jain (Yale University; CT, USA) the 2025 winner of the Bioanalysis Rising Star Award (BRSA; formerly the New Investigator Award).
The BRSA is an annual award that recognizes and promotes the work of talented early-career scientists, offering researchers a springboard to help establish themselves in the exciting world of bioanalysis.
This year’s winner, Abhishek Jain, was nominated by Caroline Johnson (Yale School of Public Health; CT, USA) who commented:
“Dr Abhishek Jain is an exceptional bioanalyst whose contributions have transformed cancer metabolomics and microbiome research. His innovative approaches have propelled scientific discovery and empowered the global research community with transformative tools and open data resources.
Dr Jain spearheaded the development of a large-scale metabolomics dataset from over 5,000 samples, including colorectal cancer tumors and gut microbial cultures, uncovering critical molecular differences between right- and left-sided liver metastases. His multi-omics approach offered invaluable insights for personalized medicine, bridging fundamental science with clinical relevance. His work has been recognized at major conferences within the clinical and metabolomics communities.”
As the winner of the BRSA, Abhishek will present his work on a Bioanalysis Zone webinar in December 2025. He also receives a 1-year subscription to Bioanalysis, a contribution towards travel costs to attend a conference, complementary free access publication of his next accepted paper, and an exclusive interview with Bioanalysis Zone.
Abhishek won the public vote after three finalists were shortlisted by the judges. The other finalists were Amanda Smythers (Harvard Medical School; MA, USA) and Alejandro Rodriguez (Genentech; CA, USA).
Videos introducing the research of each finalist are available to view at www.bioanalysis-zone.com/awards.
You can view further details of the 2025 BRSA and the profiles of winners from previous years here.
About Bioanalysis Zone
Since launching in 2011, Bioanalysis Zone has attracted over 20,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research, exclusive interviews, webinars and commentaries. Join the Bioanalysis Zone Twitter and LinkedIn group for updates.
About Taylor & Francis
Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.
Our 2,500+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies.
Taylor & Francis is proud to be a Global Certified Accessible™ publisher and our operations and all our print publications are certified CarbonNeutral®.
